Intestinal nutrient flow alteration via jejunal bypass

Intestinal nutrient flow alteration via jejunal bypass" refers to the physiological changes induced by surgical procedures such as duodenal–jejunal bypass (DJB), which redirect ingested nutrients away from the proximal small intestine directly into the jejunum. This rerouting enhances exposure of the mid-gut to undigested nutrients, activating local nutrient-sensing mechanisms. These mechanisms involve enteroendocrine cells that secrete hormones like GLP‑1 and peptide YY in response to increased luminal nutrients. The process triggers gut-brain-liver signaling pathways that suppress hepatic glucose production independently of insulin levels or food intake. Such interventions have demonstrated rapid improvements in glycemic control in animal models and humans with type 2 diabetes mellitus and obesity. However, "intestinal nutrient flow alteration via jejunal bypass" is not itself a discrete molecular target but describes an anatomical/physiological intervention affecting multiple downstream targets including receptors for gut hormones and neural circuits involved in metabolic regulation[1][2][3]. This entry is considered incorrect as a therapeutic target because it does not refer to any single molecule, receptor, enzyme, transporter or other canonical druggable entity but instead describes an anatomical/surgical manipulation resulting in complex physiological effects.

Other names

Jejunal nutrient sensing alterationDuodenal-jejunal bypass-induced nutrient flow changeDJB-mediated intestinal nutrient rerouting

Not applicable; however, the physiological effect involves enhanced delivery of nutrients to the jejunum leading to activation of gut hormone signaling and neural pathways that regulate glucose production and metabolism.